课题基金 / 基金详情

EFFECTIVENESS OF HTLV-III ANTIBODY SCREENING

EFFECTIVENESS OF HTLV-III ANTIBODY SCREENING
HTLV-III 抗体筛查的有效性
批准号:
2312864
负责人:
GIRISH N VYAS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-30 至 1995-09-30

项目摘要

项目成果

GIRISH N VYAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of this project is to develop a flow cytometry detection system (FCDS) for human lymphocytes infected with HIV-1. Optimal conditions for fixation have been established; these not only delineate the presence of intracellular HIV, but also result in inactivation of infectious HIV. Furthermore, primary and secondary antibody reactions have also been characterized. The primary antibody is specific for p24, and the secondary antibody consists of the f(ab')2 fragment of a fluorescein-conjugated, goat anti-mouse immunoglobulin antibody. The system is sensitive enough to detect one HIV-infected cell in 10,000 uninfected cells in experimentally infected human T-lymphoid cell lines. The FCDS is currently being used to examine samples from people known to be at high risk of HIV infection (hemophiliacs and their sexual partners) and from randomly selected blood donors. The system has also been modified to include the use of leu M3 phycoerythrin-labelled monoclonal antibody (CD14) for identifying infected monocytes. Low levels of apparently positive cells have been detected in the leu M3 negative cells. Experiments are currently under way to identify whether or not these cells are infected with HIV.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Human immunodeficiency virus seroprevalence among blood product recipients in San Francisco before transfusion.
旧金山血液制品接受者输血前人类免疫缺陷病毒血清阳性率。
DOI: 10.1046/j.1537-2995.1989.29289146827.x
发表时间: 1989
期刊: Transfusion
影响因子: 2.9
作者: [Hwang,LY, Beasley,RP, Busch,MP, Lane,PK, Vyas,GN]
通讯作者: Vyas,GN
Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase.
在丙氨酸氨基转移酶升高的血清阴性供体中,通过聚合酶链反应很少检测到乙型肝炎和丙型肝炎病毒基因组。
DOI: 10.1046/j.1537-2995.1994.34894353458.x
发表时间: 1994
期刊: Transfusion
影响因子: 2.9
作者: [Sankary,TM, Yang,G, Romeo,JM, Ulrich,PP, Busch,MP, Rawal,BD, Vyas,GN]
通讯作者: Vyas,GN
Absence of HIV-1 DNA in high-risk seronegative individuals using high-input polymerase chain reaction.
使用高输入聚合酶链反应检测高危血清阴性个体中 HIV-1 DNA 的缺失。
DOI: 10.1097/00002030-199110000-00008
发表时间: 1991
期刊: AIDS (London, England)
影响因子: --
作者: [Lee,TH, el-Amad,Z, Reis,M, Adams,M, Donegan,EA, O'Brien,TR, Moss,AR, Busch,MP]
通讯作者: Busch,MP
Resolution of infection status of human immunodeficiency virus (HIV)-seroindeterminate donors and high-risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high-prevalence a
通过聚合酶链反应和病毒培养解决人类免疫缺陷病毒 (HIV) 血清不确定供体和高危血清阴性个体的感染状态:高流行率中不存在持续性静默 HIV 1 型感染
DOI: 10.1046/j.1537-2995.1992.32692367191.x
发表时间: 1992
期刊: Transfusion
影响因子: 2.9
作者: [Eble,BE, Busch,MP, Khayam-Bashi,H, Nason,MA, Samson,S, Vyas,GN]
通讯作者: Vyas,GN
8
    IN VITRO INACTIVATION OF VIRUSES IN BLOOD COMPONENTS
    IN VITRO INACTIVATION OF VIRUSES IN BLOOD COMPONENTS
    IN VITRO INACTIVATION OF VIRUSES IN BLOOD COMPONENTS
    IN VITRO INACTIVATION OF VIRUSES IN BLOOD COMPONENTS
    国内基金
    海外基金
    HTLV-1病毒通过调控细胞应激颗粒抑制天然免疫并促进病毒复制的机制研究
    • 批准号:
      32370147
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2023
    • 负责人:
      赵铁军
    • 依托单位:
    PCBP1在HTLV-1感染诱导炎症和致癌过程中的调控作用及其机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      苏芮
    • 依托单位:
    B细胞在HTLV-1相关脊髓病的作用及机制研究
    • 批准号:
      U22A20296
    • 项目类别:
      联合基金项目
    • 资助金额:
      255.00万元
    • 批准年份:
      2022
    • 负责人:
      林毅
    • 依托单位:
    HTLV-1病毒通过HBZ-miR455-AK4/RHOC途径促进白血病发生的分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      54万元
    • 批准年份:
      2022
    • 负责人:
      马广勇
    • 依托单位: